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Abstract Proliferating cells and tumour cells maintain a high 
glycolytic rate even under aerobic conditions. FT02B cells, a rat 
hepatoma cell line, show high activities of glycolytic enzymes. 
Within a culture period of 48 h the cell number increases 5-fold. 
Replacement of glucose by pyruvate in the culture medium lowers 
glycolytic enzyme activity and prevents proliferation. Transfec-
tion assays revealed that glucose deprivation dramatically 
decreases the transcriptional activities of the Spl-dependent 
aldolase and pyruvate kinase promoters leading to reduced 
reporter gene expression. Spl binding activity is also inhibited by 
ocadaic acid, an inhibitor of protein phosphatase 1. Western blot 
analyses with nuclear extracts from FT02B cells cultured in the 
presence or absence of glucose revealed differences in the 
phosphorylation state of Spl. From these results we conclude 
that glucose increases the amount of the dephosphorylated form 
of Spl which has a higher DNA binding activity. As a 
consequence gene expression of the glycolytic enzymes is 
increased which is a prerequisite for cell proliferation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
One of the characteristics of rapidly growing cells is their 
ability to degrade glucose glycolytically at high rates. This 
enables tumor cells [1-3] and controlled proliferating cells 
[4] to produce more than 50% of their energy, and a remark-
able amount of anabolic precursors for biosynthetic pathways 
from glycolysis. Crabtree described the inhibition of oxygen 
consumption by the addition of glucose resulting in enhanced 
aerobic glycolysis in tumour tissues [5]. This phenomenon has 
been demonstrated also in proliferating thymocytes [6]. Mito-
gen-stimulated rat thymocytes cultured in a conventional me-
dium containing glucose induce their glycolytic enzymes 8-10-
fold in the S-phase of the cell cycle and divide within a culture 
period of 72 h [7-9]. Deprivation of glucose from the medium 
prevents glycolytic enzyme induction and proliferation of thy-
mocytes [4]. The genetic basis underlying these biochemical 
observations is not known. 
The promoter regions of aldolase and pyruvate kinase genes 
contain various Spl binding sites [10,11], and Spl is known to 
play a critical role in the transcriptional regulation of glyco-
lytic enzymes [12-15]. 
In this report we show that withdrawal of glucose from the 
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culture medium decreases glycolytic enzyme activities and in-
hibits proliferation of FT02B cells. This rat hepatoma cell 
line contains the isoenzymes aldolase A and pyruvate kinase 
M2, which are missing a glucose response element in their 
promoter region. Nevertheless the promoters of aldolase and 
pyruvate kinase are markedly activated by high concentra-
tions of glucose. 
The aim of this paper was to elucidate the mechanism by 
which glucose affects the promoter activities of aldolase and 
pyruvate kinase. In gel shift experiments with nuclear extracts 
of FT02B cells, we show that glucose treatment of the cells 
causes increased binding of Spl to its consensus sequence. The 
glucose-mediated increased binding of Spl to DNA is due to a 
shift to the dephosphorylated form of Spl in the nucleus. This 
is the first report showing that glucose treatment of prolifer-
ating cells decreases the amount of phosphorylated Spl and 
consequently increases its DNA binding efficiency. 
2. Materials and methods 
2.1. Materials 
The pGL3Basic vector, the luciferase assay system and DEAE-dex-
tran were purchased from Promega (Heidelberg, Germany); ocadaic 
acid, sodium salt was obtained from Calbiochem Inc. (Bad Soden/ 
Ts.). Antibodies used in competition assays and imrnunoblottings 
were from Santa Cruz Biotechnology (Santa Cruz, USA) and 
[a-32P]dATP was from Amersham Buchler (Braunschweig, Germany). 
Phosphatase, alkaline and lysis buffer were products of Boehringer 
(Mannheim, Germany). 
2.2. Cell preparation and cell culture 
FT02B rat hepatoma cells were grown in DMEM/Ham's F-12 
medium supplemented with 5% heat-inactivated fetal calf serum, 
200 U ml"1 penicillin G and 100 U ml-1 streptomycin at 37°C. Cells 
that were used for nuclear extracts and enzyme activity measurements 
were treated as follows: when the cells had just reached confluence the 
medium was removed and the cells were washed with phosphate-buf-
fered saline. They were incubated for 6 days in a glucose-free RPMI 
1640 medium that was supplemented with 5% heat-inactivated fetal 
calf serum deficient in glucose (Biochrom KG, Berlin, Germany), 200 
U ml-1 penicillin G, 100 U ml"1 streptomycin, 15 mM HEPES and 
with either 10 mM pyruvate or 24 mM glucose. 
2.3. Enzyme activity measurements 
Cell extracts were obtained by ultrasonication of the cells in Krebs 
saline buffer (KSP) for five separate periods of 6 s at 70 W with a 
Branson sonifier. The extracts were maintained between 0 and 4°C 
during sonication. The activities of glycolytic enzymes were assayed at 
37°C immediately after sonication by the following methods: aldolase 
and hexokinase as described by Bergmeyer, GraBl and Walter [16], 
pyruvate kinase according to Fujii and Miwa [17], 6-phosphofructo-1-
kinase according to Crane and Sols [18] and lactate dehydrogenase as 
described by Vassault [19]. 
2.4. Luciferase reporter constructs 
Aldolase A and pyruvate kinase M2 promoters were cut with the 
appropriate restriction enzymes and inserted 5' upstream of the luci-
ferase reporter gene in the commercially available luciferase basic 
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vector (pGL3Basic). The aldolase promoter fragment —727 to +141 
and the pyruvate kinase M2 fragment —454 to +78 were cloned into 
the Sstl-Bglll sites of pGL3Basic. 
2.5. Cell transfections and treatments 
FT02B cells were transfected by DEAE/dextran with 5 |ig of the 
indicated plasmid construct according to the standard protocol of the 
technical manual of the Promega mammalian transfection system. 
After treatment with the DNA/DEAE-dextran mixture the cells 
were incubated with glucose-free RPMI 1640 medium supplemented 
with 10% glucose deficient fetal calf serum (Biochrom) in the presence 
of 24 mM glucose or 10 mM sodium pyruvate or 24 mM glucose and 
100 nM ocadaic acid. Cells were harvested 48 h after transfection. 
Transfected cells were harvested with a rubber policeman, washed 
with phosphate-buffered saline, and resuspended in 300 ul lysis buffer. 
After 5 min at room temperature the extracts were centrifuged for 10 
min and the supernatants were used for luciferase assay or determi-
nation of protein concentration. 
2.6. Nuclear extracts and electrophoretic mobility shift assays 
(EMSA) 
Nuclear extracts from FT02B cells were prepared according to 
Dignam et al. [20]. FT02B cells were subjected to the treatment de-
scribed above. Protein concentration was quantified with the Bradford 
reagent (BioRad Laboratories, Richmond, CA, USA). For mobility 
shift assays the following probes were used: 
(A): A fragment of the aldolase A promoter containing two GC 
boxes and spanning from position +14 to —84. 
(B): A fragment of the pyruvate kinase M2 promoter containing 
two GC boxes and spanning from position +15 to —86. 
Ten fmol 32P end-labeled fragments, 1 ug double-stranded poly 
(dldC) and 5 |xg nuclear protein were incubated for 30 min at room 
temperature in binding buffer (20 mM Tris-HCl, 50 mM KC1, 5 mM 
MgCl2, 0.5 mM DTE, 5% (v/v) glycerol, pH 8.0). The binding com-
plex was separated by 5% polyacrylamide gel electrophoresis at 4°C in 
1 XTGE (25 mM Tris-HCl, 190 mM glycine, 1 mM EDTA, pH 8.3) at 
35 mA. 
2.7. SDS-polyacrylamide gel electrophoresis and immunoblotting 
Nuclear proteins were separated by vertical SDS-polyacrylamide gel 
electrophoresis according to Laemmli [21] and blotted to nitrocellu-
lose using an LKB Novablot semidry transfer apparatus according to 
the manufacturers instructions. Immunoblots were probed with the 
anti-Spl antibody, filters were incubated with an alkaline phosphatase 
conjugated goat anti-rabbit antibody and developed as described by 
Blake et al. [22]. 
3. Results and discussion 
3.1. Glucose requirement for glycolytic enzyme induction and 
proliferation 
In F T 0 2 B cells, a rat hepatoma cell line, cultured in a 
glucose-free medium in which glucose is replaced by 10 m M 
pyruvate the relative maximal activities of the glycolytic en-
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Fig. 1. Relative glycolytic enzyme activities of FT02B cells cultured 
in the presence or absence of glucose. Enzyme activities were deter-
mined in extracts prepared from FT02B cells cultured in RPMI 
1640 medium containing either 0 mM glucose/10 mM pyruvate or 
24 mM glucose. For details see Section 2. 
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Fig. 2. Analysis of the cell number of proliferating FT02B cells cul-
tured in the presence or absence of glucose. Numbers of cells cul-
tured in 10 ml of a medium containing either 0 mM glucose/10 mM 
pyruvate or 24 mM glucose were counted at 24 h intervals during a 
48 h culture period in more than three separate experiments. 
zymes hexokinase, 6-phosphofructo-l-kinase, pyruvate kinase 
and lactate dehydrogenase are significantly lower (Fig. 1). 
Moreover these cells do not proliferate either (Fig. 2). 
F T 0 2 B cells grown in medium containing 24 m M glucose 
show 2-5-fold increases in glycolytic enzyme activities within 
48 h of culture (Fig. 1). Thus, glycolytic enzyme induction and 
proliferation of F T 0 2 B cells depend on the presence of glu-
cose in the culture medium. 
3.2. Effect of glucose on Spl binding 
To examine the effect of glucose deprivation from the cul-
ture medium on the binding efficiency of Spl we performed 
electrophoretic mobility shift assays using promoter fragments 
of aldolase and pyruvate kinase containing two G C boxes 
each. Nuclear extracts were prepared from F T 0 2 B cells cul-
tured in the presence or absence of glucose. As indicated in 
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Fig. 3. Effect of glucose on Spl binding in vivo. Electrophoretic 
mobility shift assays were performed using: A: a fragment of the al-
dolase promoter spanning from position —84 to —200 containing 
two GC boxes, and B: a fragment of the pyruvate kinase promoter 
spanning from position +15 to —86 containing two GC boxes. The 
following nuclear extracts were used: lanes 1: nuclear extract from 
FT02B cells cultured in the presence of 24 mM glucose; lanes 2: 
nuclear extract from FT02B cells cultured in the presence of 0 mM 
glucose/10 mM pyruvate; lanes 3: nuclear extract from FT02B cells 
cultured in the presence of 24 mM glucose incubated with anti-Spl 
antibody. 
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Fig. 4. Effect of glucose and ocadaic acid on the transcriptional ac-
tivity of aldolase and pyruvate kinase promoter-controlled expres-
sion of a luciferase reporter gene. FT02B cells were transfected 
with 5 ug of the luciferase reporter gene constructs containing the 
aldolase A or pyruvate kinase M2 promoters. Luciferase activity 
was assayed 48 h post-transfection of the promoter-reporter con-
structs into FT02B cells, which were maintained in the presence or 
absence of glucose or in the presence of glucose plus ocadaic acid 
as indicated in the figure. The luciferase activity measured in the 
control cells (+glucose) was set to 100%. Activities were normalized 
to equal amounts of protein. All values represent the mean of six 
independent experiments. 
Fig. 3, glucose treatment leads to an increase in Spl binding 
activity at its binding sites. With both fragments one main 
complex was formed. Glucose deprivation from the culture 
medium decreased the intensity of the band indicated by ar-
row. The formation of the complex was efficiently inhibited in 
the presence of an Spl-specific antibody. Therefore it can be 
deduced that the complex contains the Spl transcription fac-
tor. 
From these results we conclude that DNA binding effi-
ciency of Spl is increased in the presence of glucose. This 
could be caused either by a change in the absolute quantity 
of Spl molecules in the cell or by posttranslational modifica-
tion of the transcription factor. 
3.3. Influence of glucose on Spl-dependent transactivation 
To examine the functional activity of aldolase and pyruvate 
kinase promoters in the presence or absence of glucose, we 
placed (i) a fragment of the aldolase promoter spanning from 
position —717 to +141 or (ii) a fragment of the pyruvate 
kinase promoter spanning from position —454 to +78 in the 
pGL3-basic vector. This vector is designed to test a promo-
ter's activity by using luciferase as a reporter gene. FT02B 
cells were chosen for the transient gene expression studies to 
ensure the presence of signal transduction cascades and cell 
surface receptors characteristic of a tumor cell line. Transient 
expression of luciferase derived from the promoter-reporter 
construct was determined after transfection of FT02B cells, 
by assaying luciferase activity 48 h post-transfection. As 
shown in Fig. 4 deprivation of glucose from the culture me-
dium resulted in a marked decrease of transcription activity 
with both promoters compared to cells cultured in the pres-
ence of 24 mM glucose. 
Previously it has been shown that glucose activation of Spl 
is attenuated by ocadaic acid, an inhibitor of protein phos-
phatase 1 (PP1) [23,24]. To determine if the Spl activity in 
FT02B cells is modified by a phosphatase, the effect of oca-
daic acid was examined. Addition of ocadaic acid to the glu-
cose containing culture medium inhibited glucose activation 
of aldolase and pyruvate kinase promoters (Fig. 4). 
3.4. Western blot analysis 
In order to examine if glucose-mediated increases in the 
DNA-protein complexes are due to an increase in the amount 
of Spl, or to the activation of existing Spl, Western blot 
analysis of nuclear extracts from glucose deprivated and con-
trol cells was carried out. The amount of Spl did not change 
as a result of glucose treatment of the cells (Fig. 5A). Recently 
Armstrong et al. reported that Spl is a phosphoprotein and 
that phosphorylation by Casein kinase II lowers its DNA 
binding efficiency in liver [25]. Comparing equal quantities 
of nuclear extract obtained from cells cultured in a glucose 
containing medium and cells cultured in a glucose deprived 
medium we found that nuclear extracts from glucose starved 
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Fig. 5. A: Western blot analysis of Spl. 25 |xg of nuclear extracts prepared from control and glucose deprivated cells were run on a 7.5% SDS-
polyacrylamide gel. After transfer to a nitrocellulose filter, the filter was blotted with a monoclonal antibody against Spl. The upper arrow in-
dicates the phosphorylated form of Spl, the lower arrow the dephosporylated form [27]. B: Nuclear extracts, as indicated, were subjected to 
Western blot analysis using an antibody against the catalytic subunit of PP1 (CS1). 
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cells contain a higher percentage of phosphorylated Spl (Fig. 
5A). From the immunoblot it appears that the nuclear extract 
from the control cells contains more proteolytic degradation 
products of Spl, although both nuclear extracts were pre-
pared in parallel and under identical conditions. This phe-
nomenon was found in five separate preparations of nuclear 
extract. We assume that dephosphorylated Spl is more sus-
ceptible to proteolytic degradation than phosphorylated Spl. 
The observed differences in the phosphorylation state of Spl 
suggest differences in the amount or activity of PP1. PP1 has 
been shown to dephosphorylate Spl in vivo [26]. In order to 
determine if glucose treatment had any effect on the amount 
of phosphatase in FT02B cells, we performed an SDS-PAGE 
with nuclear extracts. As shown in Fig. 5B the blot was in-
cubated with an antibody against the catalytic subunit of PP1 
(CS1). Both nuclear extracts from the control and the glucose 
deprived cells cross-reacted with a specific anti-CSl antibody 
to the same extent. From this result we conclude that not the 
amount but the activity of PP1 is reduced in glucose deprived 
cells. 
From our results it appears that interconversion of Spl by 
phosphorylation and dephosphorylation is an effective mech-
anism in regulating the expression of glycolytic genes in the 
FT02B tumor cell line. 
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